Herpes Zoster on the Brain and Vaccinations: Dr. Kevin Winthrop
Dr. Kevin Winthrop reviews several abstracts that look at herpes zoster infection, including abstracts #0849 and #2002 as presented at the 2020 ACR annual meeting.
Dr. John Cush RheumNow
5 years 9 months ago
Antimalarials and Retinopathy: Dr. Janet Pope ( @Janetbirdope) #ACR20
https://t.co/6XqWxK8lCM https://t.co/YpDsEudGup
Dr. John Cush RheumNow
5 years 9 months ago
Olmstead County (Mayo) population study shows 47 lupus nephritis (LN) pts betw 1976-2018. Incidence doubled from 1980s (0.6 per 100K) to 2018 (1.2/100K); with women of childbearing age as the most affected group. #ACR20 Abstr#0274 https://t.co/a8GvILLse0 https://t.co/qlueI7LHc4
2020 evidence-based clinical practice guideline for the prevention, diagnosis, and treatment of Lyme disease was cooperatively developed the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR).
Patients with rheumatic and inflammatory diseases who develop COVID-19 share risk factors for severe disease with the larger population, including older age, male sex, obesity, and hypertension, but also are at increased risk if they are on corticosteroids, French investigators reported.
Dr. John Cush RheumNow
5 years 9 months ago
ACR has released 2 free powerpoint slide decks featuring select RA and SLE abstracts from #ACR20 (a 3rd late-breaking slide deck is yet to come!). Download here>> https://t.co/CiNH0xfs7J
Dr. John Cush RheumNow
5 years 9 months ago
#FDA Pfizer presentation of their new COVID vaccine data https://t.co/Zk3DF3ycIF
Dr. John Cush RheumNow
5 years 9 months ago
Stop Making these mistakes because of COVID-19 Concerns:
1. Keep your medical appointments - Drs offices have changed to keep you SAFE
2. Get scheduled blood tests - LabCorp, Quest labs are very safe to go to
3. Restart usual scheduled visits,eye exams, bone density, annual PCP
Dr. John Cush RheumNow
5 years 9 months ago
Upadacitinib Effective in Biologic Refractory Psoriatic Arthritis #ACR20
https://t.co/uE4ZmfulbP https://t.co/OzpX6hLw6O
Dr. John Cush RheumNow
5 years 9 months ago
Taiwanese claims data on new RA (2003‐2016) shows decreasing incidence over time. After RA Dx the life expectancy was 26.3 yrs; lifetime cost US$ 72,953. On avg RA pts live 4.97 years less (historically this was 8-11yrs); has biologic era improved this? https://t.co/gHbZx1bw0A
Dr. John Cush RheumNow
5 years 9 months ago
Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush #ACR20
https://t.co/jOzAkLzNEc https://t.co/lPM8bbHDr7
Dr. John Cush RheumNow
5 years 9 months ago
1st refractory to DMARD can be bad omen. RA Study showed 41/402 (10%) were multi-DMARD refractory (MR) and 18% achieved remission/LDAS. DMARD MR predicted by erosions, younger age, high baseline DAS28, delta-DAS < 1.2 1st 6 mos (OR 11.12) https://t.co/KxdK97uuSI
Dr. John Cush RheumNow
5 years 9 months ago
UTSW Rheum Gr Rounds - Treatment options for Sarcoidosis @UTSWIMchief https://t.co/cGm6VhsTfc
Dr. John Cush RheumNow
5 years 9 months ago
#FDA, Summary of Dr. Aron Halls CDC presentation and updates on COVID-19 https://t.co/DUAftAKq0R
Dr. John Cush RheumNow
5 years 9 months ago
#FDA hearing on Covid vaccines - shows current seroprevalence by state, currently < 10% seroprevalence with higher rates in children and young adults https://t.co/8eG5cKQBiA
